Videos

Dr. Ramy Sedhom discusses how embedded psychosocial care in oncology may improve access, engagement and emotional support during cancer care.

Urologist Dr. Susan MacDonald breaks down the differences between soft tissue and blood cancers while highlighting common and rare disease types.

MD Anderson’s Dr. Wendy Woodward discusses breath-hold techniques, insurance hurdles, and proton therapy’s role in reducing radiation cardiac toxicity.

Dr. Tony Anderson speaks about fertility preservation options for men and women before cancer treatment, emphasizing early testing and timely referral.

This segment highlights a real-world patient perspective on immunotherapy tolerability in advanced melanoma. Ms. Haupert shares that she experienced minimal side effects during treatment, primarily limited to intermittent fatigue that required occasional rest days. She reflects on feeling fortunate to maintain a relatively stable quality of life throughout therapy. She also notes ongoing monitoring of thyroid function following treatment, illustrating how some immune-related effects may require continued follow-up even after therapy completion. Dr. Morrison provides broader clinical context, explaining that many patients receiving immunotherapy experience mild or manageable side effects, while a smaller proportion may develop more significant toxicities that require intervention. He emphasizes that these effects are generally well understood and can be managed effectively with appropriate monitoring and care. Overall, this segment reinforces variability in patient experience while highlighting the importance of ongoing surveillance in advanced melanoma.

Learn which immunotherapy side effects matter most—rash, breathing changes, diarrhea, fatigue—and why labs track liver, kidney, thyroid inflammation.

Dr. Tony Anderson discusses key questions after a cancer diagnosis and fertility planning.

We are entering an era where "cure," specifically a functional cure, is no longer a forbidden word in the myeloma community.

New T-cell engagers and ADCs show survival gains in pretreated small cell lung cancer, signaling long-awaited progress and more treatment options for patients.

Although AI can support complex oncology decision-making, physician judgment remains critical to ensuring safe, individualized patient care.

From blurred vision to brain surgery, a melanoma patient shares treatment twists, immunotherapy setbacks, and why TIL therapy offers new hope.

Learn how advanced melanoma is staged and treated, from immunotherapy to hospital support, with clinician insights and a patient’s perspective.

Lauren Yerkes, founder of POST SWIM, discusses the jarring shift to breast cancer survivorship and the daily practice of reclaiming body confidence.

The ATOMIC Trial shows how adding immunotherapy to chemotherapy may reduce recurrence risk and improve outcomes in stage III dMMR colon cancer.

The National Ovarian Cancer Coalition (NOCC) delivers free meals to ovarian cancer patients, easing treatment burdens and supporting caregivers nationwide.

Researchers identified gut microbiome markers that predict melanoma return after surgery, allowing doctors to personalize immunotherapy for patients.

Rezetapopt showed a 44.4% response rate and durable responses over 8 months in ovarian cancer with p53 Y220C mutation, with mostly mild side effects.

Dietitian Stephanie Meyers shared practical strategies at the LiveLung SCLC Patient Summit to help patients manage appetite loss and digestive issues.

Dr. Sunil Dutta discusses treatment approaches and managing side effects in esophageal cancer, including nutrition and patient support strategies.

At NCCN 2026, Dr. Charles Peyton emphasized patient engagement and shared decision-making as expanding treatment options reshape bladder cancer care.

New guidelines back FDA‑approved subcutaneous therapy as effective as IV, letting patients choose faster, easier dosing without losing safety.

Switching from IV to subcutaneous injection eases hard vein access, cuts clinic time, and boosts comfort with faster treatment and fewer side effects.

Dr. Maryam Lustberg discusses the REVITALIZE trial testing CO2 laser therapy to treat vaginal dryness and GSM in breast cancer survivors.

A man with small cell lung cancer describes carboplatin-related hearing loss, fatigue and daily challenges that have reshaped his life, while holding onto perspective and resilience.

At NCCN 2026, Anjali Albanese discussed how young adults with cancer face grief, isolation and loss of control that impact their emotional well-being.

Dr. Michael K. Wong explains why immunotherapy makes skin hypersensitive, and how to spot red-flag reactions during melanoma care.

Dr. Thomas Flaig highlights the importance of multidisciplinary care and clinical trials in guiding personalized bladder cancer treatment decisions.

Dr. Michael Wong shares "sun smart" tips for melanoma survivors, debunking tanning myths and highlighting why clothing is better than sunscreen alone.

The latest episode of the "Breast Cancer Briefing" podcast highlights the evolving integration of GLP-1 agonists into the breast cancer treatment armamentarium.

An expert discusses the need to tailor treatment duration in bladder cancer, balancing improved outcomes with toxicity and exploring new tools.